Common phenotype and etiology in warfarin embryopathy and X-linked chondrodysplasia punctata (CDPX)
Savarirayan
R
R
D000925:Anticoagulants / Q000009:adverse effects*; D001192:Arylsulfatases / Q000037:antagonists & inhibitors / Q000235:genetics; D002806:Chondrodysplasia Punctata / Q000201:enzymology / Q000209:etiology / Q000235:genetics*; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced / Q000201:enzymology / Q000235:genetics*; D008040:Genetic Linkage; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D018811:Maternal Exposure / Q000009:adverse effects; D009154:Mutation; D010641:Phenotype; D011247:Pregnancy; D014859:Warfarin / Q000009:adverse effects*; D014960:X Chromosome
D000925:Anticoagulants; D014859:Warfarin; C110155:ARSL protein, human; D001192:Arylsulfatases